March 2020 – Market Research Insights

IV Iron Drugs Market Size Is Projected To Reach USD 2.90 Billion By 2026: Grand View Research Inc.

San Francisco, 31 March 2020: The Report Intravenous Iron Drugs Market Size, Share & Trends Analysis Report By Product (Iron Sucrose, Iron Dextran, Ferric Carboxymaltose), By Application (Chronic Kidney Disease, Inflammatory Bowel Disease, Cancer), and Segment Forecasts, 2019 – 2026

The global intravenous (IV) iron drugs market size is expected to reach USD 2.90 billion by 2026,expanding at a CAGR of 7.2% during the forecast period, according to a new report by Grand View Research. Growing prevalence of chronic diseases, noncompliance of oral drug treatment and recent approvals of novel products are the key factors driving the IV iron drugs market. However, some of the factors that are restraining the market include the adverse side effects, stringent regulations, availability of nutraceutical alternatives, and complex approval process.

Iron is one of the crucial components in the hemoglobin and plays an important role in the transportation of oxygen throughout the body. It also takes part in several biological processes such as energy metabolism, formation of collagen, the synthesis of heme, formation of myoglobin, immune system functions, and neurotransmitter production. Around 30% of anemia in women and children in developing nations is caused by deficiency of iron according to a survey conducted by the Vitamin and Mineral Nutrition Information System in 2017. Growing cases of chronic kidney diseases, iron deficiency anemia in gastroenterology, gynecology and oncology and growing cohort with high rate of unresponsive oral therapy is expected to drive the demand for these drugs. Furthermore, increasing healthcare expenditure and high accuracy, sensitivity and easy access of intravenous iron drugs fuels the market growth.

Among the products, the ferric carboxymaltose segment dominated the global intravenous iron drugs market in 2018 and is expected to grow significantly due to its increasing application in drug discovery processes, superior performance, and reduced cost. Ferric carboxymaltose is marketed as Injectafer in North America and under the name of Ferinject outside North America. Asia Pacific is projected to demonstrate the highest CAGR during the forecast period, while North America held the largest market share in 2018.

Access Research Report of IV Iron Drugs Market @ https://www.grandviewresearch.com/industry-analysis/intravenous-iron-drugs-market

Further Key Findings From the Study Suggest:

Among the applications, chronic kidney disease segment held the largest IV iron drugs market share in 2018, due to increasing prevalence and geriatric population
Ferric carboxymaltose is expected to maintain its dominance through the forecast period due to the increasing application in drug discovery, superior performance and reduced cost
Asia Pacific is projected to exhibit the fastest growth during the forecast period, which can be attributed to the increasing prevalence of chronic diseases in the region, improving healthcare infrastructure, and rising per capita healthcare expenditure
Key players operating in the intravenous iron drugs market include Allergan, Inc.,AMAG Pharmaceuticals. Inc.,Daiichi Sankyo Company, Ltd., Sanofi, Fresenius Medical Care AG & Co., Vifor Pharma Management Ltd., Pharmacosmos A/S, Shield Therapeutics Plc, and American Regent. Inc.

Browse more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the intravenous iron drugs market report on the basis of product, application, and region:

Intravenous Iron Drugs Product Outlook (Revenue, USD Million, 2015 – 2026)

Iron Dextran
Iron Sucrose
Ferric Carboxymaltose
Others

Intravenous Iron Drugs Application Outlook (Revenue, USD Million, 2015 – 2026)

Chronic Kidney Disease
Inflammatory Bowel Disease
Cancer
Other Diseases

Intravenous Iron Drugs Regional Outlook (Revenue, USD Million, 2015 – 2026)

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Access Press Release of IV Iron Drugs Market @ https://www.grandviewresearch.com/press-release/global-intravenous-iron-drugs-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information:www.grandviewresearch.com

COVID-19 Treatment Market Trends Analysis And Forecast From 2020-2027: Grand View Research Inc.

The COVID-19 outbreak caused due to Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2), affecting millions of people globally. The outbreak of the pandemic COVID-19 has impelled the pharmaceutical industry into action, with a race to develop both therapeutic and preventive interventions. Exponentially increasing cases worldwide requiring short and long term respiratory support and multiple partnerships for the development of treatments with clinical trials underway are some of the major factors expected to drive the market over the forecast period.

The contagious coronavirus is having a potential economic impact and implications on most of the sectors including the pharmaceutical industry. Governments all over the world are now responding to the threat of COVID-19 with all the essential measures such as social distancing, nationwide lockdown, travel restrictions, and large-scale quarantines that are anticipated to negatively impact the businesses and consumer spending.

Get More Information Regarding COVID-19 Treatment Market @ https://www.grandviewresearch.com/industry-analysis/covid-19-treatment-market

According to the WHO, SARS-CoV-2 has spread to over 150 countries with over 460,000 confirmed cases and over 20,000 deaths as of 27th March 2020. Based on treatment, the market is segmented into disease treatment drugs and preventive vaccines. Antiviral for disease treatment and symptom relief segment includes off label drugs and pipeline drugs. Geographically, the market has been divided into North America, Europe, Latin America (LATAM), Asia Pacific, and Middle East & Africa (MEA).

Currently, there are no drugs approved by the U.S. FDA or EU for the treatment of coronavirus disease. However, the only antiviral drug approved in China is Favilavir, developed by Zhejiang Hisun Pharmaceutical. Favilavir was approved by the National Medical Products Administration of China on 18^th February 2020. According to China’s Ministry of Science and Technology, favilavir is one of three drugs which demonstrated encouraging profile for blocking coronavirus in early clinical trials. The other two drugs are Gilead Sciences, remdesivir, and anti-malarial drug, chloroquine are also having promising results. 1M doses of Chloroquine from Bayer & 30M doses of hydroxycholroquine from Novartis received emergency use authorization for the treatment of Covid-19 by the U.S. FDA.

In addition, the China International Exchange and Promotive Association for Medical and Health Care (CPAM) also recommends the use of lopinavir; ritonavir in combination with nebulized alfa-interferon for the treatment of SARS-CoV-2.

Furthermore, market players are in the process of developing life-saving and life-enhancing medicines or vaccines for COVID-19. Several universities and key players such as Moderna , Inc.; DIOSynVax; Imperial College London, UK; Oxford University, UK; and Inovio Pharmaceuticals, Inc. are focusing on developing vaccines for coronavirus. For instance, the U.S. National Institute of Health (NIH) has started COVID-19 vaccine trial on 16 March 2020 in Seattle.

The fatalities are higher in people over 85 years of age. Although older people are at risk, the younger population is also affected by the disease. According to an article published in the World Economic Forum in March 2020, among the 500 people being hospitalized in the U.S., 20% were aged between 20 to 44 years and 18 % were aged between 45-54 years.

People with existing illnesses such as cardiovascular disease, chronic respiratory disease, hypertension, and diabetes are expected to experience a higher than average fatality rate. Moreover, according to the Chinese CDC, males are more vulnerable to becoming severely ill with the virus than women. The male fatality rate is 2.8% and the female fatality rate is 1.7%.

Despite tremendous efforts, the first vaccine is expected to take at least a year to commercialize. Market players are also focusing on the development of both antiviral drugs and vaccines independently or through collaberations. For instance, Gilead Sciences is evaluating a drug, remdesivir, a nucleoside analog currently in phase 3 clinical trial in Asia Pacific and U.S. for the treatment of COVID-19.

Access Research Report of COVID-19 Treatment Market @ https://www.grandviewresearch.com/industry-analysis/covid-19-treatment-market

Chemoinformatics Market Likely To Touch At USD 21.18 Billion By 2024: Grand View Research Inc.

San Francisco, 31 March 2020: The Report Chemoinformatics Market Analysis By Application (Chemical Analysis, Drug Discovery, Drug Validation) Segment Forecasts to 2024

The global chemoinformatics market is expected to reach over USD 21.18 billion by 2024 according to a new report published by Grand View Research, Inc. Some major determinants influencing the market growth include the constantly improving modern drug development processes, increasing use of in-silico techniques in research, and the advantages associated with employing the chemoinformatics approach, such as the reduction in the overall R&D expenditure during the drug development process.

The ever increasing growth of the drug development market will boost the demand for chemoinformatics owing to its numerous applications in drug designing at various stages. Right from target identification to its development as a potential drug candidate, chemoinformatics tools play a crucial part.

The significant contributions of the varying in silico tools in the generation of hits through the High Throughput Screening(HTS) process, target compound selection, virtual structure generation, Pharmacokinetic property and toxicity prediction of chemical compounds, and the quantitative-structure relationship determination have been a major driving force for the growth of the chemoinformatics market.

The heavy costs incurred along with the long time span invested in the drug discovery process has made the integration of the chemoinformatics techniques essential in the research activities. It aids the scientists and chemical researchers in making better decisions pertaining to drug discovery and other related research studies. Furthermore, the increasing demand for efficient and effective medicines, rising investments in R&D, growing geriatric population, and the burgeoning number of individuals with lifestyle related diseases are expected to positively reinforce the market growth. The key applications of the chemoinformatics tools and softwares in drug designing and discovery has been its largest application and is expected to grow further with further advances in the drug discovery process.

Chemoinformatics has made marked contributions to the areas of chemical drug development and research. The growth of this field is driven by the continually generated raw data in screening operations and research studies. Chemoinformatics in silico tools aid in effective data management, which facilitate data retrieval and analysis thus providing large databases of accessible information to scientists involved in both, the drug development process and other research related studies.

The development of three dimensional chemical structure databases has been a significant achievement in the field of chemoinformatics as it has significantly aided the research process. Applications of chemoinformatics platforms in computer-assisted synthesis designing, computer-assisted structure elucidation, and chemometrics have further contributed to the market growth.

The advancements in computational technology have been a high impact rendering driver for the market growth. In this direction, the development of super computers and silicon graphics computer for calculations, 3D structure generation, molecular graphics, and complex data display have been pivotal in propelling the growth of the chemoinformatics market. With the advent of advanced WEB technologies and their incorporation in the in-silico computational techniques have totally revolutionized this field.

The increasing needs for advanced and efficient technologies to yield better results has made the chemoinformatics area an indispensable part of the pharmaceutical industry. The surging need for therapeutically-effective medicines coupled with the increasing investments in the R&D area and the advancements in computer technologies provide lucrative opportunities to the market for it to grow and flourish in the near future.

Access Research Report of Chemoinformatics Market @ https://www.grandviewresearch.com/industry-analysis/chemoinformatics-market

Further key findings from the study suggest:

In 2015, North America dominated the chemoinformatics market with a revenue share of over 36% on account of the following factors: the high investments pertaining to the R&D initiatives, technological advancements, the presence of major players in the drug manufacturing industry, and the increasing prevalence of lifestyle-related diseases. With respect to the global R&D spending, North America holds the largest share. Also, it holds a major share in the ADME-toxicology market that further spurs the growth of the chemoinformatics market.
Asia Pacific is identified as one of the fastest growing regional markets, growing at a lucrative CAGR of 18.3% during the forecast period. The growth of this market can be attributed to the growing research activities being conducted in economies, such as India, China, and Singapore. The key advantages associated with undertaking research activities in these countries include the low manufacturing and labor costs and the less stringent regulations, which attract many multinational players to the Asia Pacific region. Additionally, the government initiatives and funds that are deployed to improve the R&D infrastructure will further drive the market growth.
Key players operating in the market include Agilent Technologies, Inc., BIOVIA (Accelrys), Bio-Rad Laboratories, Inc., CambridgeSoft Corp., ChemAxon, Inc., ACD/Labs, Inc., Schrödinger, LLC, and Chemical Computing Group, Inc. Additionally, the rising demand for in-silico techniques in the research sector is expected to provide new market entrants with profitable opportunities thereby driving the market growth.

Browse more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the chemoinformatics market by applications:

Global Chemoinformatics Market, by Application (USD Billion, 2013 – 2024)

Chemical Analysis
Drug Discovery
Drug Validation
Others

Chemoinformatics Market Regional Outlook, by Revenue (USD Billion, 2013 – 2024)

North America
Europe
Asia Pacific
Latin America
MEA

Access Press Release of Chemoinformatics Market @ https://www.grandviewresearch.com/press-release/global-chemoinformatics-market

About Grand View Research

For More Information:www.grandviewresearch.com

Breakthrough Therapy Designation Market Size Is Poised To Reach USD 144.6 Billion By 2025: Grand View Research Inc.

San Francisco, 31 March 2020: The Report Breakthrough Therapy (BT) Designation Market Analysis Report By Application (Oncology, Infectious Diseases, Rare Diseases, Autoimmune Diseases, Pulmonary Diseases, Neurological Disorders), And Segment Forecasts, 2018 – 2025

The global breakthrough therapy designation market is anticipated to reach USD 144.6 billion by 2025, according to a new report by Grand View Research, Inc. Breakthrough Therapy (BT) designation is granted to drugs that display substantial results in the treatment of life-threatening diseases in initial stages of the drug development process. Expedited regulatory process in North America and EU regions is driving growth. Increase in the number of innovative molecules receiving the BT status, coupled with rise in the demand for orphan drugs as well as those for the treatment of cancer, is anticipated to boost the market over the forecast period.

The development time of BT therapy is 30.0% to 50.0% lesser than those without the designation. This significantly increases the net present value of investigational molecule. Reduction in the development time of these drugs is expected to accelerate their approval process as compared to standard drugs as well as boost growth opportunities. The BT tag also increases the value of the drug due to its high scientific value.

There has been a consistent rise in the number of drugs receiving BT status in the U.S., and this trend is also expected to drive the number of applications submitted for the same, thereby contributing to the market growth.

Access Research Report of Breakthrough Therapy Designation Market @ https://www.grandviewresearch.com/industry-analysis/breakthrough-therapy-bt-designation-market

Further Key Findings From the Study Suggest:

The infectious diseases segment dominated the market in 2016. However, it is expected to exhibit moderate growth in the forecast period owing to decline in sales of blockbuster drugs such as Harvoni and Sovaldi
Oncology is expected to be the dominating segment over the forecast period owing to rise in the demand for cancer medicines and increase in the number of oncology molecules gaining BT status. As of 2017, the number of molecules gaining BT status is the highest in this segment
The rare diseases segment is estimated to exhibit fastest growth owing to rise in demand and increase in the R&D pipeline of orphan drugs
North America is expected to dominate the market over the forecast period owing to well-established intellectual property laws and preference of patients and healthcare professionals for innovative medicines
Some of the key players are F. Hoffmann-La Roche Ltd; Gilead; Novartis AG; Pfizer, Inc.; AbbVie, Inc.; Janssen Global Services, LLC; Bristol-Myers Squibb Company; Eli Lilly and Company; Sanofi; Regeneron; AcadiaPharmaceuticals, Inc.; Boehringer Ingelheim GmbH; Amgen, Inc.; AstraZeneca; and GlaxoSmithKline plc.

Browse more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the breakthrough therapy market report on the basis of application and region.

Breakthrough Therapy Designation Application Outlook (Revenue, USD Million, 2015 – 2025)

Oncology
Infectious Diseases
Rare Diseases
Auto Immune Diseases
Pulmonary Diseases
Neurological Disorder
Others

Breakthrough Therapy Designation Regional Outlook (Revenue, USD Million, 2015 – 2025)

North America
Europe
Asia Pacific
Latin America
Middle East and Africa (MEA)

Access Press Release of Breakthrough Therapy Designation Market @ https://www.grandviewresearch.com/press-release/global-breakthrough-therapy-bt-designation-market

About Grand View Research

For More Information:www.grandviewresearch.com

Retail E-commerce Market Overview, Analysis And Forecast To 2027: Grand View Research Inc.

The global retail e-commerce market is expected to witness high growth during the forecast period, favored by growing digital dependency and convenient online shopping channels. E-commerce evolved amid a busy lifestyle and a plethora of options available to shop from the comfort of home. Convenience is the major factor driving the overall online shopping market growth. Moreover, lower prices compared to brick-and-mortar retail stores further attracted price-conscious customers to browse online. Customers can find their interested products by visiting the website and gain additional insights on various products.

Shopping over the eCommerce website has multiple benefits, including multiple payments and goods options, home delivery, and easy return, among others. The simplified and user-friendly website allows easier navigation of various product categories with the help of the search system, thereby increasing the indulgence of the consumer. Moreover, eCommerce websites aided in reducing rush at stores, increasing the reach of retailers, and allowing “shop from anywhere” to the consumer with a hectic work schedule. Additionally, the door-step delivery further eradicated transportation or traveling trouble while websites remain active 24*7 for shopping.

Online retail has made products more accessible to the consumer across the countries, which is proving vital in the 2020 global crisis due to Coronavirus pandemic. The severity of pandemic has affected the daily life of people across North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa (MEA). Social distancing has been used as the most effective tool to across the country to stop the third stage of infection called “community spread’. Hence, governments have been imposing lockdown or curfew to restrict the movement of people on the street. However, the curfew situation has created panic among people regarding the fulfillment of their basic necessities, which led to overstocking of food and grocery items. Although the government has been allowing grocery and medical stores to operate for a stipulated time, the pandemic is restricting people from visiting crowded supermarkets.

During the lockdown and self-quarantine period, the internet has played a crucial role in keeping people connected. The internet is being leveraged not only by the company to allow “Work From Home’ (WFH) but also gives freedom to order online without venturing out of their home. The shopping on an eCommerce website is allowed by the government provided workers in warehouse’s and delivery workers are taking care of the hygiene factor in the process of shopping.

Get More Information @ https://www.grandviewresearch.com/industry-analysis/retail-e-commerce-market

According to Quantum Metric, a predictive retail analytics company, the quarantine and limited movement imposed by the U.S. government during COVID-19 outbreak had led to a surge in online shopping across the numerous states of the U.S. While some of the retail category such as grocery, vegetable, and cleaning supplies among other may add to the growth of retail e-commerce market, other products such as sports, home service, clothing, and home décor among other would witness a major setback in the overall earning. For instance, a WSM business, Williams-Sonoma, Inc., had been benefitting from strong eCommerce growth and West ELM. However, its growth is being grappled by the growing case of Coronavirus, as the closing of the store is expected to weigh its margin.

Some manufacturers are launching their products only through the online retail medium during this pandemic. For instance, Redmi canceled its launch event scheduled on March 12 and opted for an online-only launch to avoid gathering of people. Such strategies are probing the customers to buy products over the internet on account of the physical retail market absence. Furthermore, the spread of Coronavirus has affected the supply chain and operations of major mobile brands, including Apple, Oppo, Xiaomi, Huawei, and Samsung, among others.

The retail e-commerce industry has been witnessing fraud through counterfeit goods delivery. Besides, online monetary transactions have allowed hackers to break into the website and get consumer information. The fraudulent activity and scams on the retail eCommerce website have further increased during the COVID-19 outbreak. Amazon called out over 1 million products with a fraudulent claim related to the cure of the virus. According to The Wall Street Journal report from cybersecurity firm Proofpoint, the emails containing mention of Coronavirus in a single mail has spiked since the outbreak across the world. Additionally, there are new websites scamming consumers in paying for the low-quality masks, personal protective equipment, and sanitizers, among others, or there is no delivery post online payment.

The Indian market offers excellent opportunities for overall retail e-commerce market growth. Despite the large Indian population, only people residing in the metro or other main cities buy products through online sale channel. However, an increase in the mobile phone and internet banking use is expected to provide bright prospects to overall industry growth over the forecast period and during the COVID-19 crisis period. Furthermore, urbanization and smart city development have contributed to the westernized lifestyle, which is further changing the shopping pattern from traditional to online. India, along with other major countries spread across the Asia Pacific and Europe, is fighting the Coronavirus by practicing social distancing, as the country is under lockdown from March 25 to April 14. This is expected to increase online shopping for groceries and other necessities.

Ecommerce companies have started catering life essential and niche products to consumers for the period until the countries recover from Coronavirus pandemic. Companies such as Amazon, eBay, Instacart, and Walmart WMT are witnessing decent growth as a consumer are hoarding on food and daily supplies. Other online grocery companies such as Grofers, and BigBasket’s are witnessing humungous growth as their revenue double in the first two weeks of March. The eCommerce companies would be focusing on sustainable distribution while leveraging the opportunity to grow and gain an edge over competitors during the pandemic. The other eCommerce vendors would be waiting for the economy to revive so that the consumers can indulge in purchasing luxury & comfort items apart from just buying the products for survival.

Access Research Report of Retail E-commerce Market @ https://www.grandviewresearch.com/industry-analysis/retail-e-commerce-market

Disaster Recovery Solutions Market is Predicted to Observe a Tremendous Growth, With a CAGR of 36.5% From 2018 To 2025 : Grand View Research Inc.

San Francisco, 31 March 2020: The Report Disaster Recovery Solutions Market Size, Share & Trends Analysis Report By Type (Backup & Recovery, Data Security, Replication), By Deployment, By End Use, By Enterprise Size, And Segment Forecasts, 2018 – 2025

The global disaster recovery solutions market size is expected to reach USD 26.23 billion by 2025, according to a new study by Grand View Research, Inc., registering a strong CAGR of 36.5% during the forecast period. The market has been experiencing a significant increase in demand owing to growing instances related to infrastructure failure, cyberattacks, natural disasters, and other internal and external threats. Unanticipated events such as these cause disruption in business operations, resulting in massive losses for organizations.

Various companies are reconsidering their plans for backup and recovery of important business applications and data over the past few years owing to increasing occurrences of planned, manmade disasters. For instance, malicious attacks such as WannaCry and Locky ransomware in 2017 led to the loss of thousands of encrypted files and systems. Government and private sectors incurred considerable financial losses owing to these attacks.

Businesses are increasingly incorporating disaster recovery (DR) solutions in their business continuity strategies, making DR plans a critical part of IT priorities. Moreover, increasing awareness about the benefits of implementing such solutions and growing adoption of cloud-based solutions are promoting the adoption of disaster recovery solutions among SMEs.

Access Research Report of Disaster Recovery Solutions Market @ https://www.grandviewresearch.com/industry-analysis/global-disaster-recovery-solutions-market

Further key findings from the study suggest:

By type, the backup and recovery solutions segment is expected to exhibit the highest CAGR of 38.8% over the forecast years, owing to easy, cost-efficient, flexible, and secure backup and recovery of critical business data in the event of a disaster
Among professional services, managed services are presumed to register the highest CAGR of 37.0% over the forecast period, as they help curb costs while ensuring unaltered service quality
On the basis of enterprise size, the small enterprise segment is anticipated witness the fastest growth from 2017 to 2025, owing to increasing adoption of cloud-based solutions by SMEs
Currently, hybrid deployment is the most preferred method for deploying disaster recovery solutions and is expected to retain its popularity over the forecast period, owing to the fact that it helps in lowering on-premise installation costs
By end use, the government and public sector is anticipated to witness the highest adoption over the coming years, owing to growing number of digitalized economies, especially in developing nations
Asia Pacific is anticipated to expand at the highest CAGR of 40.0% over the forecast period, owing to increasing IT investments in developing nations such as China and India
Key industry participants operating in the market include Unitrends, IBM Corporation, iland Internet Solutions, Sungard Availability Services, and Microsoft Corporation.

Browse more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/emerging-and-next-generation-technologies

Grand View Research has segmented the global disaster recovery solutions market based on type, deployment, enterprise size, end use, and region:

Disaster Recovery Solutions Type Outlook (Revenue, USD Million, 2014 – 2025)

Backup & Recovery
Data Security
Replication
Professional Service
- Integration & Deployment
- Managed Services
- Others

Disaster Recovery Solutions Deployment Outlook (Revenue, USD Million, 2014 – 2025)

Hybrid Cloud
Public Cloud
Private Cloud

Disaster Recovery Solutions Enterprise Size Outlook (Revenue, USD Million, 2014 – 2025)

Large Enterprise
Small & Medium Enterprise

Disaster Recovery Solutions End-use Outlook (Revenue, USD Million, 2014 – 2025)

BFSI
Government & Public Sector
Healthcare
IT & Telecommunication
Manufacturing
Retail
Others

Disaster Recovery Solutions Regional Outlook (Revenue, USD Million, 2014 – 2025)

North America
Europe
Asia Pacific
Latin America
MEA

Access Press Release of Disaster Recovery Solutions Market @ https://www.grandviewresearch.com/press-release/disaster-recovery-solutions-market

About Grand View Research

For More Information:www.grandviewresearch.com

Smart Thermostat Market Size Is Expected To Reach USD 2.99 Billion By 2022 : Grand View Research Inc.

San Francisco, 31 March 2020: The Report Smart Thermostat Market Analysis By Technology (Wi-Fi, ZigBee, Others) And Segment Forecasts To 2022

The global smart thermostat market is expected to reach USD 2.99 billion by 2022, according to a new study conducted by Grand View Research, Inc. These thermostats enable users to remotely control their air conditioning as well as heating systems through wireless connectivity and mobile apps. Smart thermostats form an integral part of smart homes and have gained high traction in developed regions such as Europe and North America. The industry is anticipated to witness a high adoption of these gadgets as they display the energy consumption level in real-time and are capable of adjusting to ambient conditions automatically. These devices can be connected to the internet and offer analytics and performance measurement tools through web-based portals. They are usually an integral part of the home automation ecosystem.

Energy utility retailers play a vital role in promoting the adoption of these devices in households. Many utilities offer these products as a part of their home energy management schemes. The involvement of energy retailers amplifies the potential for the smart thermostat industry growth. Additionally, the proliferation of mobile phones and their convergence with thermostats make these products much more attractive for the end-users.

The growing penetration of smartphones, rising per unit energy costs, the need for effective energy management solutions, and the favorable regulatory scenario are expected to propel the market growth over the coming years. The increased penetration of Near Field Communication (NFC) and ZigBee home automation devices is further expected to augment the demand. However, the high cost of devices and the associated data security concerns may restrain the growth prospects of this industry.

Access Research Report of Smart Thermostat Market @ https://www.grandviewresearch.com/industry-analysis/smart-thermostat-market

Further key findings from the study suggest:

The market primarily includes devices based on connectivity technologies such as Wi-Fi, ZigBee, and other technologies including NFC, Bluetooth, and Ethernet. ZigBee-enabled devices are expected to gain a significant share with the increasing consumers’ shift toward home automation devices.
North America and Europe, together, accounted for about 90% of the overall market share (in terms of revenue) in 2015 owing to the high demand for such devices in the region and favorable government mandates. The surge in the constructional activities and growing popularity of smart homes is expected to spur the demand.
Key players, including Honeywell International, Inc., Nest Labs, Inc. (Google), and Ecobee, together, accounted for over 40% of the overall market share (in terms of revenue) in 2015. OEMs have been focusing on the development of new products as well as upgrading the existing product portfolio. Strategic agreements and collaborations have been practiced for gaining competitive advantage.

Browse more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/emerging-and-next-generation-technologies

Grand View Research has segmented the smart thermostat market on the basis of technology and region:

Smart Thermostat Technology Outlook (Revenue, USD Million, 2012 – 2022)

Wi-Fi
ZigBee
Others (Near Field Communication (NFC), Bluetooth, and Ethernet)

Smart Thermostat Regional Outlook (Revenue, USD Million, 2012 – 2022)

North America
Europe
Asia Pacific
Latin America
MEA

Access Press Release of Smart Thermostat Market @ https://www.grandviewresearch.com/press-release/global-smart-thermostat-market

About Grand View Research

For More Information:www.grandviewresearch.com

Fuel Cell Vehicles Market Likely To Touch At USD 1.75 Billion By 2025: Grand View Research Inc.

San Francisco, 31 March 2020: The Report Fuel Cell Vehicles Market Size, Share & Trends Analysis Report By Region (Europe, North America, Asia Pacific), Competitive Landscape, And Segment Forecasts, 2018 – 2025

The global fuel cell vehicles market size is expected to reach USD 1.75 billion by 2025, according to a new report by Grand View Research, Inc., registering a 33.7% CAGR during the forecast period. This rapid growth can be attributed to increase in investments by governments over the world for development and adoption of fuel cells.

Fuel cell vehicles ensure emission-free operation, which will effectively reduce the carbon footprint and significantly drive product demand over the next few years. The key factor expected to drive the industry is advancements in fuel cell technology. Ongoing advancements have helped match performance with conventional fuel vehicles, with respect to power output and user experience.

Adoption of fuel cell vehicles worldwide is expected to rise over the forecast period due to increasing awareness about reducing harmful emissions, strict environmental regulations, and growing incentives for use of clean energy.

Access Research Report of Fuel Cell Vehicles Market @ https://www.grandviewresearch.com/industry-analysis/fuel-cell-vehicle-market

Further key findings from the report suggest:

The global fuel cell vehicles market was valued at USD 194.5 million in 2017 and is expected to exhibit a CAGR of 33.7% over the forecast years owing to growing trend of clean energy consumption
Several government initiatives and programs to encourage the use of fuel cell vehicles have led to an increase in their adoption, subsequently increasing their demand over the past few years
North America accounted for the largest market share in 2017 and is anticipated to exhibit a CAGR of over 36.0% over the forecast period. This can be attributed to massive investments by the United States Department of Energy (DoE) in development of fuel cells and improvement of infrastructure
Although the Europe fuel cell vehicles market accounted for just over 3.0% of the overall market revenue in 2017, it is anticipated to be the fastest growing region with CAGR of more than 38.0% over the forecast period
Key market players include Toyota Motor Corporation, Honda Motor Company, Ltd., and Hyundai Motor Company. Apart from these, there are several other automobile manufacturers that are in the process of launching their fuel cell vehicles.

Browse more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/automotive-and-transportation

Grand View Research has segmented the global fuel cell vehicle market on the basis of region:

Fuel Cell Vehicles Regional Outlook (Volume, Units; Revenue, USD Billion, 2014 – 2025)

North America
Europe
Asia Pacific

Access Press Release of Fuel Cell Vehicles Market @ https://www.grandviewresearch.com/press-release/global-fuel-cell-vehicles-market

About Grand View Research

For More Information:www.grandviewresearch.com

Vaccine Delivery Devices Market Trends, Demand, Production, Analysis and Forecast to 2025 : Grand View Research Inc.

San Francisco, 30 March 2020: The Report Vaccine Delivery Devices Market Size, Share & Trends Analysis Report By Devices (Syringes, Jet Injectors, Other Devices), By Route of Administration (Intradermal Vaccination, Intramuscular Vaccination, Subcutaneous Vaccination), And Segment Forecasts, 2018 – 2025

The global vaccine delivery devices market size is expected to reach USD 6.21 billion by 2025, according to a new report by Grand View Research, Inc. The market is primarily driven by growing immunization programs, financial support from government & nongovernment organizations, increasing vaccination initiatives & campaigns, and rising prevalence of infectious diseases globally. Growing research in the field of vaccines and development of new products is also contributing to the growth of the market.

Adoption of needle-free approach for administering these products is gaining momentum due to growing awareness and demand to avoid pain & injuries associated with the use of a needle stick. Data by the Centers for Disease Control and Prevention states that an estimated 385,000 sharp injuries including needle stick injuries occur every year in hospitals in the U.S. Advancing technologies in administering vaccines and their increasing adoption is propelling market growth. Rising interest of various key players, national institutions, and organizations in novel delivery technologies is expected to further contribute to market growth.

Various governments and international organizations are increasingly investing in the development of vaccination programs. For instance, the UK government also announced funding up to £1 million from its Global Challenges Research Fund through Medical Research Council to investigate the Zika virus and its transmission. Organizations such as GAVI Alliance, Bill & Melinda Gates Foundation, Path, and WHO are actively involved in the field of vaccines. Many governments are also undertaking several immunization programs on priority.

Access Research Report of Vaccine Delivery Devices Market @ https://www.grandviewresearch.com/industry-analysis/vaccine-delivery-devices-market

Further key findings from the report suggest:

The syringes segment held majority of the revenue share in 2016 due to increasing vaccination programs, spreading immunization coverage, and technological advancements
Jet injectors is expected to register highest growth during the forecast period owing to rising concerns regarding needle stick injuries and growing preference for needle-free technologies
Intramuscular vaccination dominated the route of administration segment in 2016 as majority of vaccines are given through this route owing to its advantages
North America dominated the global vaccine delivery devices market owing to increasing awareness levels, high adoption of technology, and rising prevalence of infectious diseases
Some of the key players include Becton Dickinson & Company, Bioject Medical Technologies, Inc. (Inovio Pharmaceutical Inc.); Gerresheimer AG; PharmaJet; Corium International, Inc.; and SCHOTT AG

Browse more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global vaccine delivery devices market on the basis of devices, route of administration, and region:

Vaccine Delivery Devices Outlook (Revenue, USD Million, 2014 – 2025)

Syringes
Jet Injectors
Other Devices

Vaccine Delivery Devices Route of Administration Outlook (Revenue, USD Million, 2014 – 2025)

Intradermal Vaccination
Intramuscular vaccination
Subcutaneous Vaccination
Other Vaccinations

Vaccine Delivery Devices Regional Outlook (Revenue, USD Million, 2014 – 2025)

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Access Press Release of Vaccine Delivery Devices Market @ https://www.grandviewresearch.com/press-release/global-vaccine-delivery-devices-market

About Grand View Research

For More Information:www.grandviewresearch.com

Point of Care Infectious Disease Testing Market Size Is Projected To Reach USD 1.9 Billion By 2025: Grand View Research Inc.

San Francisco, 30 March 2020: The Report Point of Care Infectious Disease Testing Market Size, Share & Trends Analysis Report By Disease (HIV POC, HBV POC, Influenza/Flu POC, TB & drug-resistant TB POC), By End-use, And Segment Forecasts, 2018 – 2025

The global point-of-care infectious disease testing market size is expected to reach USD 1.90 billion by 2025, according to a new report by Grand View Research, Inc. The emerging trend of patient-centric services coupled with escalating incidence rates of complicated infectious disorders is expected to upsurge the demand for portable and accurate detection devices, thus resulting in market growth. The potential in these devices to enable rapid detection of infectious diseases is attributive for the estimated market.

Moreover, revolutionizing patient care brought about by these devices is responsible for the rising demand for decentralized testing settings. Rise in the investments for R&D and development of new products is expected to spur progress in point-of-care infectious disease diagnostics market through to 2025.

For instance, development of a new ‘lab-on-a-disc’ technology developed by an EU project research team aids in the diagnosis of different infectious diseases including malaria. It enables faster diagnosis as a consequence of implementation of point-of-care treatment. This allows precise drugs administration thus influencing adoption rate.

Access Research Report of Point of Care Infectious Disease Testing Market @ https://www.grandviewresearch.com/industry-analysis/point-of-care-infectious-disease-diagnostics-testing-market

Further key findings from the report suggest:

HIV POC is estimated to account for the largest share owing to the rising incidence of this disease
Advances in the bio sensing technology for the early detection with sensitivity is expected to fuel revenue generation in the coming years
Moreover, companies are engaged in embracing a quality management approach for the introduction of novel tests for HIV diagnosis
TB and drug resistant TB is anticipated to witness lucrative demand in the coming years as a result of rise in the incidence rate of drug resistance TB
Demand for the development of inexpensive, rapid, simple, and accurate tests that are able to detect multiple biomarkers simultaneously is expected to boost progress
Implementation of fully or partially integrated nano/microscale technologies in developing DR-TB diagnostic devices is anticipated to fuel progress in the segment
Clinics accounted for the largest revenue share owing to the higher usage of rapid testing kits in clinics
North America dominates the space with adequate administration support, well-established healthcare framework, and extensive research & technology upgradation
Asia Pacific region is expected to showcase the fastest growth over the forecast period due to rising incidence and prevalence rates of infectious diseases with suitable government support
The major players in the sector include Siemens Healthineers, Trivitron Healthcare, F. Hoffmann-La Roche Ltd, Alere, Quest Diagnostics, Inc, BD & Company, Chembio Diagnostics Inc,Trinity Biotech, Cardinal Health,Bio-Rad Labs Inc.,bioMérieux SA, Thermo Fisher Scientific Inc, Sight Diagnostics Ltd.,Gene POC, Ortho-Clinical Diagnostics, and OJ-Bio Ltd.
Companies are entering into collaborations with academic institutions, private, and public entities to enhance their market share

Browse more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/clinical-diagnostics

Grand View Research has segmented the point-of-care infectious disease diagnostics market on the basis of disease, end-use, and region:

Point-of-Care Infectious Disease Diagnostics Disease Outlook (Revenue, USD Million; 2014-2025)

HIV POC
Clostridium difficile POC
HBV POC
Pneumonia or Streptococcus associated infections
Respiratory syncytial virus (RSV) POC
HPV POC
Influenza/Flu POC
HCV POC
MRSA POC
TB and drug-resistant TB POC
HSV (Herpes Simplex Virus) POC
Other infectious disease POC

Point-of-Care Infectious Disease Diagnostics End-Use Outlook (Revenue, USD Million; 2014-2025)

Hospitals
Clinics
Home
Assisted Living Healthcare Facilities
Laboratories
Others

Point-of-Care Infectious Disease Diagnostics Regional Outlook (Revenue, USD Million; 2014-2025)

North America
Europe
Asia Pacific
Latin America
Middle East and Africa (MEA)

Access Press Release of Point of Care Infectious Disease Testing Market @ https://www.grandviewresearch.com/press-release/global-point-of-care-infectious-disease-diagnostics-testing-market

About Grand View Research

For More Information:www.grandviewresearch.com

	knowledgesourcing1 on Modular Instruments Market Exp…
	knowledgesourcing1 on Spirometer Market is Predicted…
	james cofer on Ostomy Care And Accessories Ma…
	violintec on Railway Wiring Harness Market…
	Russel David on HR Analytics Market Projected…

	knowledgesourcing1 on Modular Instruments Market Exp…
	knowledgesourcing1 on Spirometer Market is Predicted…
	james cofer on Ostomy Care And Accessories Ma…
	violintec on Railway Wiring Harness Market…
	Russel David on HR Analytics Market Projected…